Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tajmeeli was an Arabic-language digital health and medical aesthetics platform focused on educating consumers about cosmetic procedures and helping them connect with providers. The company served Arabic-speaking users across the Middle East, Africa, Turkey, and other markets with procedure information, doctor discovery, and related teleconsultation-style services. It was founded by Jordan Boshers and grew to more than 1 million monthly users before being acquired by RealSelf in January 2021. Tajmeeli was not a drug-development biotech company; it operated more as a healthcare content, marketplace, and patient-acquisition platform in aesthetic medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tajmeeli.